Selection of the Right Partner

Key Decision For many drug developing companies, the selection of the right CDMO that will fulfill the activities from Cell Line Development to the manufacturing […]

Read more

CMC in early stage: a customer testimonial.

Thierry Bernardi, PharmaD, is CEO of BioFilm Pharma, a startup developing new antibiotics that specifically target the bacterial biofilm. Their candidates are news entities and […]

Read more

The Target Product Profile

Approximately 25% of late phase trials fail due to commercial and strategic issues. A more robustly developed Target Product Profile (TPP) could reduce this risk […]

Read more

An effective CMC Strategy

“Strategy” is defined as a course of activities designed to lead to an overall aim. Thus, the CMC regulatory compliance strategy is the course of […]

Read more

Why CMC Matters ?

What happens when no sufficient effort is put on CMC ? Starting from your research lab, where you found an interesting compound that might end […]

Read more

3Biotech’s blog reopens!

3Biotech (re)opens their blog today ! We will fill this blog weekly with our views on drug development, CMC challenges for small and big molecules, and […]

Read more

Vous avez un projet ? Prenez contact avec 3Biotech !



      • Le siège :
        66 Avenue des Champs-Élysées Paris 8ème, France


    • Nos bureaux :
      Spaces, 126 avenue du Général Leclerc, 92100 Boulogne-Billancourt, FRANCE

Telephone : 33 (0)1 46 51 04 34